O

Optomed Oyj
OMXH:OPTOMED

Watchlist Manager
Optomed Oyj
OMXH:OPTOMED
Watchlist
Price: 3.955 EUR -0.25% Market Closed
Market Cap: 76.2m EUR
Have any thoughts about
Optomed Oyj?
Write Note

Optomed Oyj
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Optomed Oyj
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
O
Optomed Oyj
OMXH:OPTOMED
Cash Equivalents
€7.1m
CAGR 3-Years
-12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
R
Revenio Group Oyj
OMXH:REG1V
Cash Equivalents
€13.5m
CAGR 3-Years
-6%
CAGR 5-Years
-8%
CAGR 10-Years
19%
M
Modulight Oyj
OMXH:MODU
Cash Equivalents
€409k
CAGR 3-Years
-39%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Cash Equivalents
€6.9m
CAGR 3-Years
45%
CAGR 5-Years
41%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Cash Equivalents
€1.8m
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
20%
No Stocks Found

Optomed Oyj
Glance View

Market Cap
77.5m EUR
Industry
Health Care

Optomed Oyj engages in the provision of handheld fundus cameras and eye-screening solutions. The company is headquartered in Oulu, Oulun and currently employs 115 full-time employees. The company went IPO on 2019-12-09. The Group's Parent Company, Optomed Oyj, is responsible for, among other things, the management of the Group as well as finance and accounting functions, human resources, legal affairs and corporate communication. The Group's business is managed through two reportable segments: Devices and Software. The Devices segment develops, commercializes and manufactures easy-to-use and affordable handheld fundus cameras. The Software segment develops and sells screening software for diabetic retinopathy and cancer screening for healthcare organizations. The Optomed Group consists of the parent company Optomed Oyj and four subsidiaries in Finland, China, the USA and Hong Kong.

OPTOMED Intrinsic Value
5.584 EUR
Undervaluation 29%
Intrinsic Value
Price
O

See Also

What is Optomed Oyj's Cash Equivalents?
Cash Equivalents
7.1m EUR

Based on the financial report for Dec 31, 2023, Optomed Oyj's Cash Equivalents amounts to 7.1m EUR.

What is Optomed Oyj's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
29%

Over the last year, the Cash Equivalents growth was -16%. The average annual Cash Equivalents growth rates for Optomed Oyj have been -12% over the past three years , 29% over the past five years .

Back to Top